Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Ching-Yi Tien

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|March 13, 2025
Discovery of <b>YJZ5118</b>: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt InhibitionJianzhang Yang, Yu Chang, Kaijie Zhou, et al.
Journal of Medicinal Chemistry|June 8, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic CoreXuzhi Lu, Zhaodi Tian, Xueqiang Li, et al.
Cancer Cell|March 28, 2017
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate CancerXiaoju Wang, Yuanyuan Qiao, Irfan A Asangani, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Nature Communications|June 6, 2020
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer developmentSunita Shankar, Jean Ching-Yi Tien, Ronald F Siebenaler, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|March 13, 2025
Discovery of <b>YJZ5118</b>: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt InhibitionJianzhang Yang, Yu Chang, Kaijie Zhou, et al.
Journal of Medicinal Chemistry|June 8, 2026
Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic CoreXuzhi Lu, Zhaodi Tian, Xueqiang Li, et al.
Cancer Cell|March 28, 2017
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate CancerXiaoju Wang, Yuanyuan Qiao, Irfan A Asangani, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancerJie Luo, Zhixiang Chen, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Rewiring Oncogenic Transcriptional Complexes with Domain-ALTeration Chimeras (DALTACs) in Prostate CancerJie Luo, Jianzhang Yang, Jean Ching-Yi Tien, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Nature Communications|June 6, 2020
An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer developmentSunita Shankar, Jean Ching-Yi Tien, Ronald F Siebenaler, et al.
Nature Communications|June 28, 2024
PIKfyve, expressed by CD11c-positive cells, controls tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
PIKfyve controls dendritic cell function and tumor immunityJae Eun Choi, Yuanyuan Qiao, Ilona Kryczek, et al.
Pageof 3